Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Pfizer
Pfizer
Endeavor Biomedicines, Inc.
National Cancer Institute (NCI)
Cancer Research UK
Cancer Research UK
Nested Therapeutics, Inc
Ikena Oncology
Eli Lilly and Company
National Cancer Institute (NCI)
Aminex Therapeutics, Inc.
University of Southern California
Memorial Sloan Kettering Cancer Center
Deciphera Pharmaceuticals, LLC
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Polaris Group
Case Comprehensive Cancer Center
Shenzhen BinDeBio Ltd.
BBB-Therapeutics B.V.
National Cancer Institute (NCI)
GE Healthcare
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
TransMolecular